Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
As the one-year anniversary of Bristol-Myers Squibb Company’s $74bn acquisition of Celgene Corporation approaches, Scrip spo…
As the one-year anniversary of Bristol-Myers Squibb Company’s $74bn acquisition of Celgene Corporation approaches, Scrip spo…
It would be hard to find a more challenging time for Michelle McMurry-Heath to join the Biotechnology Innovation Organizatio…